Email your diabetes stories to editor Oliver Jelley.

Join the expanding diabetes community on Twitter and follow us for the latest diabetes news updates at @DiabetesTimes.

We are now on YouTube where you will find interviews with leading people within the field of diabetes. Click here to visit our page. 

August 2010. It's always a tad nostalgic to skim through old emails, but that's how far back the first meeting was where it was discussed how we wanted to change diabetes care in South East Hampshire & Portsmouth. Many late nights, many meetings later, it was around September 2011, that the redesign of the diabetes model came into being.

In between that, there was the nervousness of contracts teams in hospitals, the debates with one's own Trust, the financial calculations involved, a lengthy conflict of interest panel, multiple negotiations, convincing colleagues....yet, finally we got there.The birth of the Super Six Diabetes Model.

Much has been written, many papers have been published and the mists of time make one forget who did help along the way.

Those were the days of Jim Hogan and Koyih Tan as GP commissioners, Lyn Darby as the local Commissioner, Melissa Way as the Strategy Implementation manager, Richard Jones as the Medicine Chief and Lesley Munro as the manager from the local community provider. Some steadfast supporters, and of course, three fabulous colleagues within the department who let you get on with it.

The course of time has been kind to us and about six-and-a-half years later, the model continues as we discuss the next steps.

To read more, click here. 

We publish the latest diabetes vacancies which are currently available in the UK on our dedicated jobs page here.

Diabetes Specialist Nurse at Kent Community Health NHS Foundation Trust

Diabetes Nurse at Locala Community Partnerships CIC

Diabetes Specialist Nurse at East and North Hertfordshire NHS Trust

Diabetes Specialist Nurse at Wye Valley NHS Trust

CRN Eastern Specialty Lead – Diabetes at Norfolk and Norwich University Hospitals NHS Foundation Trust

Artificial pancreas systems are a “safe and effective” treatment for people with type 1 diabetes, a study published by The BMJ has concluded.

A review of the available evidence has concluded that the use of an artificial pancreas was associated with better control of blood sugar levels for people with type 1 diabetes compared with standard treatment.

The findings show that artificial pancreas treatment provides almost two and a half extra hours of normal blood glucose levels a day, while reducing time in both high hyperglycaemia and hypoglycaemia.

To read more, click here. 

Diabetes Professional Care (DPC) has made the final of a prestigious national contest in four categories.

Healthcare Publishing & Events, the company behind the event, lined up alongside some of the industry’s biggest names at the coveted Exhibition News Awards (EN Awards) – held at Battersea Evolution in London on March 23. To read more, click here. 

A diabetes nurse has been nominated for a top health award for her “knowledge, enthusiasm and dogged determination”.

Catherine Cassell, based at Preston Grove Medical Centre in Somerset, has been shortlisted in the Patient’s Choice category for this year’s RCNi Nurse Awards. To read more, click here. 

The leading blood glucose meter for visually impaired people has been withdrawn from the market.

SuperCheck2 is no longer available for sale after the manufacturer Apollo Medical Technologies Ltd discontinued the product. To read more, click here. 

A training programme for healthcare staff developed by a diabetes nurse from North West (NW) London has been shortlisted for a HSJ award.

Diabetes consultant nurse Ruth Miller, from NW London collaboration of Clinical Commissioning Groups, developed a 10-point programme to improve basic understanding and awareness of diabetes. To read more, click here. 

Making small adjustments to existing diabetes treatments can alter how they interact with cells, and potentially make the medicines more effective, researchers have said.

The findings come from studies involving both human cells and mice in which researchers tweaked the structure of an existing treatment for type 2 diabetes. To read more, click here.